Our name and logo changed on February 1.
Please note that some materials on the site may not yet reflect this change.
Québec cystic fibrosis (CF) families now have provincial formulary access to TOBI* PODHALER*, a fast and convenient inhaled therapy for CF patients aged six and over. Through Institut National d’Excellence en Santé et en Services Sociaux (INESSS), the Québec government has become the first public payer in Canada to reimburse TOBI* PODHALER*. According to Cystic Fibrosis Canada, there are an estimated 1,200 cystic fibrosis patients in Québec. More....
Reviewed/updated: 2011-10-03
